Abstract-The mechanism by which estrogens protect against atherosclerosis is not known. We evaluated in vivo whether there is a gender difference in monocyte adhesion and subendothelial migration in hypercholesterolemic rabbits and whether any gender differences observed are due to estradiol. Monocyte adhesion and subendothelial migration were assessed in a blinded fashion by analyzing a standardized segment of aorta using a scanning electron microscope. We also assessed whether estradiol modulates induction of vascular cell adhesion molecule-1 (VCAM-1) protein using Western blot and flow cytometric analyses. We observed that male rabbits develop more monocyte adhesion and subendothelial migration than do female rabbits during hypercholesterolemia. We also observed that oophorectomized rabbits given physiological estradiol supplementation demonstrate fewer adherent and subendothelial monocytes than do oophorectomized rabbits given placebo. VCAM-1 protein expression was increased in aortae obtained from hypercholesterolemic, oophorectomized animals supplemented with placebo, and this increase was attenuated by estradiol. Finally, in cultured rabbit aortic endothelial cells stimulated with lysophosphatidylcholine, we observed an increase in VCAM-1 protein that was inhibited in a concentration-dependent fashion by estradiol. We have demonstrated in vivo that there is a gender difference in monocyte adhesion to endothelial cells and transendothelial migration after hypercholesterolemia and that this gender difference is due in part to estradiol. Our results also suggest that estradiol inhibits monocyte adhesion by inhibiting expression of VCAM-1. (Circ Res. 1999;85:377-385.)
W omen in the reproductive age group are at lower risk for developing cardiovascular disease (CVD) as compared with men of similar age. 1, 2 This gender difference has been well documented in both human and animal studies. [2] [3] [4] [5] [6] [7] Hamm et al 5 demonstrated that in nonhuman primates there was significantly more coronary artery stenosis in males than in females in response to an atherogenic diet. Furthermore, they found that differences in lipid levels did not account for this influence of gender in the development of CVD. Similar observations have been made in male and female rabbits after administration of a cholesterol (2%)-enriched diet. 6 The protection against CVD observed in females has been ascribed to estrogen. Estrogen replacement therapy in postmenopausal women reduces the risk of CVD relative to the risk in postmenopausal women who do not receive estrogen replacement. 7, 8 In support of these clinical observations, Adams et al 9 observed that ovariectomy in nonhuman primates resulted in a doubling of the extent of atherosclerosis in animals fed an atherogenic diet compared with a similar group of animals receiving estrogen replacement. Adams et al 10 also demonstrated that in animals fed an atherogenic diet, administration of 17␤-estradiol (E 2 ) resulted in the formation of a plaque area that was 50% smaller than that seen in animals given no hormone replacement. Studies in oophorectomized rabbits also showed that estrogen administration attenuated aortic accumulation of cholesterol 11 and reduced the degree of atherosclerosis after an atherogenic diet. 12 However, the mechanisms by which estrogens protect against atherosclerosis are not known.
The adhesion of monocytes to endothelial cells coupled with transendothelial migration are essential components of an inflammatory response and occur continuously throughout the entire atherogenic process. 13 We therefore decided to assess whether there was a gender difference in the number of monocytes that both adhere to and migrate across the endothelial lining of the aorta in vivo in rabbits fed a cholesterol-enriched (0.5%) diet and whether E 2 was responsible for this difference. To further elucidate possible mechanisms by which E 2 may prevent monocyte adhesion, we also assessed the role of E 2 in inhibiting expression of vascular cell adhesion molecule-1 (VCAM-1). The rabbit was selected as the animal model, because the female of this species is in persistent estrus 14 ; therefore, the animals are under the constant influence of E 2 with no compounding influence of progesterone. Furthermore, we took advantage of previous studies of the time course of lesion development in hypercholesterolemic rabbits 15 to focus this investigation on those time points at which monocyte adhesion and subendothelial migration are known to first occur.
Materials and Methods

Materials
Rabbit chow (modified laboratory rabbit diet 5321, with 0.5% cholesterol) was purchased from Purina Mills, Inc. E 2 
Animals
Male and female New Zealand White (NZW) rabbits weighing 3 to 3.5 kg were used. All animals were initially fed regular chow for 2 weeks. Certain animals then underwent oophorectomy (OVX) with placement of either placebo or E 2 pellets (1.5 mg, 60-day release). Briefly, animals were placed under anesthesia with ketamine and halothane. With a sterile technique, a midline abdominal incision was made, and the ovaries were identified and then excised after ligation of the ovarian artery and vein. The abdominal incision was then closed in layers with delayed absorbable suture. A 1-cm skin incision was then made at the nape of the neck, and the placebo or E 2 pellets were placed subcutaneously. The skin was closed with delayed absorbable sutures. All animals received prophylactic antibiotics (cefazolin, 500 mg IM). The animals were allowed to recover from surgery for the next 7 to 10 days, during which time they were fed normal chow (NC). They were then continued on NC or placed on a 0.5% cholesterol diet (HC) for 4 weeks. Animals developing evidence of postoperative infection were excluded from the study. An aliquot of blood was collected into tubes containing EDTA from each animal on a weekly basis from a peripheral ear vein to assess lipid and E 2 levels. At the end of the 4-week feeding period, animals were placed under deep anesthesia with ketamine (10 mg/kg, IM) and xylazine (40 mg/kg, IM) in preparation for perfusion fixation of the aortic tree. Certain animals were euthanized by exsanguination without perfusion fixation so that aortic tissue could be harvested for Western blotting. The animal protocol was formally approved by the Animal Research Committee of the University of California.
Protocol 4: Effects of E 2 on VCAM-1 Protein Expression in Cultured Endothelial Cells Stimulated With Lysophosphatidylcholine (Lyso-PC)
The cell groups were as follows: (1) cells incubated with vehicle, (2) cells incubated with vehicle for 48 hours followed by stimulation with 100 mol/L lyso-PC for 15 hours (10 mmol/L stock in ethanol), (3) cells incubated with 1000 pg/mL E 2 for 48 hours followed by stimulation with 100 mol/L lyso-PC for 15 hours, and (4) cells incubated with 3000 pg/mL E 2 for 48 hours followed by stimulation with 100 mol/L lyso-PC for 15 hours. Before treating the cells, the presence of estrogen receptors on the cells was confirmed with the use of reverse transcription-polymerase chain reaction (RT-PCR) as described below. In some experiments, ICI-182780 (9 ng/mL), an estrogen receptor antagonist, 16 was added in the culture medium just before addition of 3000 pg/mL E 2 . Cells were then prepared for fluorescence-activated cell sorting (FACS) as described below.
Perfusion Fixation
Perfusion fixation was carried out according to the method described by Rosenfeld et al. 15 After establishment of deep anesthesia, one of the femoral veins was exposed and cannulated for perfusion runoff. A cannula connected to a perfusion apparatus was inserted into the right carotid artery. One of the femoral arteries was also cannulated for placement of a pressure manometer to measure mean arterial perfusion pressure. Immediately before exsanguination, the animals were given a bolus injection of sodium pentobarbital, and the blood was flushed out with lactated Ringer's solution at a flow rate of Ϸ100 mL ⅐ min -1 ⅐ kg -1 body weight to yield an average intra-arterial perfusion pressure of 100 mm Hg. When the runoff was clear of blood, 2 to 4 liters of 2.5% glutaraldehyde in 0.1N phosphate buffer was perfused through at the above flow rate. After perfusion, the femoral vein and carotid artery were clamped, and the arteries were fixed under pressure for an additional 30 minutes. After perfusion fixation, the entire aorta and common iliac arteries were dissected from each animal. The vessels were cleaned of adherent fat and fascia, and a 1-cm area of aorta surrounding the celiac bifurcation was isolated and prepared for scanning electron microscopy.
Calculation of Lipid Exposure
To assure that differences in cholesterol exposure during the feeding period could not account for differences in monocyte adhesion between the groups, cholesterol exposure during the 4-week feeding period was calculated for each animal and compared with that of the other animals in the respective groups. This was done by calculating the total cholesterol, HDL, and LDL areas under the curve (AUCs) for each animal, with the following formula: AUCϭ(Y0/ 2)ϩY1ϩY2ϩY3ϩ(Y4/2), where Y0, Y1, Y2, Y3, and Y4 were total cholesterol, HDL, and LDL levels at weeks 0, 1, 2, 3, and 4, respectively. Only tissues from those animals with comparable AUCs were selected for assessment of monocyte adhesion and expression of VCAM-1 protein.
Tissue Preparation for Scanning Electron Microscopy
The segments of aorta surrounding the celiac bifurcation were opened lengthwise and pinned out on polytetrafluoroethylene. The tissue was washed in buffer, postfixed in 1% OsO 4 in PBS for 3 hours, followed by 1 hour in 1% thiocarbohydrazide and finally again in 1% aqueous OsO 4 for 2 hours, all at room temperature.
The tissue was next dehydrated in ethanol, critical point-dried with CO 2 and sputter-coated with a 300-Å layer of gold palladium. A standardized area of each specimen measuring 13.5 mm Scanning electron microscopic analysis of leukocyte adhesion and subendothelial migration. A, Low-magnification scanning electron micrograph showing the exact area evaluated in each of the NZW rabbits included in this study. The area evaluated (3000ϫ6000 m) surrounds the celiac bifurcation in the abdominal aorta. Blood flow is from bottom to top of the micrograph. Evaluation included counting both the numbers of adherent leukocytes and subendothelial macrophages (see Figures 3 and 4) , examples of which are shown in panels B through G. B, High-magnification micrograph of an adherent leukocyte. C, High-magnification micrograph of a subendothelial macrophage. D, Representative example of the small number of adherent leukocytes observed in an ovariectomized (OVX)/E 2 -treated NZW rabbit after 4 weeks of feeding 0.5% cholesterol. E, Representative example of the small number of subendothelial macrophages observed in an ovariectomized/E 2 -treated NZW rabbit after 4 weeks of feeding 0.5% cholesterol. F, Representative example of the larger number of leukocytes that adhere to the endothelium of an ovariectomized/placebo-treated NZW rabbit after 4 weeks of feeding 0.5% cholesterol. G, Representative example of the increased number of subendothelial macrophages observed in an ovariectomized/placebo-treated NZW rabbit after 4 weeks of feeding 0.5% cholesterol. Both a micrometer scale bar and magnification (ϫ) are included at the bottom of each micrograph.
Western Blot
After exsanguination, the entire aorta and iliac arteries were dissected out from the animal and cleared of adherent fat and fascia. The abdominal aorta, including the renal artery branch points, was then isolated, and VCAM-1 and, in some experiments, GAPDH were then analyzed by Western blot with a polyclonal goat, anti-human VCAM-1 and mouse monoclonal anti-rabbit GAPDH antibody. The tissues were homogenized in 50 mmol/L tetraethylammonium-HCl (pH 7.4) containing (in mmol/L) EGTA 0.1, EDTA 0.1, and DTT 0.5, as well as 1 mol/L pepstatin A and 2 mol/L leupeptin, at 4°C with the aid of a tissue grinder fitted with a polytetrafluoroethylene pestle. Protein concentration was measured by the Bradford Coomassie brilliant blue method as described by Bio-Rad Laboratories. The samples were then diluted in loading buffer (10% glycerol, 2% SDS, and 62.5 mmol/L Tris-HCl [pH 6.8], 5% ␤-mercaptoethanol, and 0.1% bromphenol blue). Fifty micrograms of protein in tissue homogenates was loaded in each lane, separated on 7.5% SDS-polyacrylamide gels, and transferred to Hybond PVDF membrane electrophoretically using a semidry transfer system (Pharmacia Biotech). Equal loading in each lane was confirmed by staining the PVDF membrane with Ponceau S solution (Sigma). The membrane was blocked for 2 hours at room temperature in PBS containing 0.1% Tween-20 and 10% nonfat milk. The membrane was incubated with VCAM-1 antibody at 1:1000 dilution for 2 hours and was washed 3 times for 15 minutes each with wash buffer (PBS containing 0.1% Tween-20). After washing, the membrane was incubated for 1 hour at room temperature with a horseradish peroxidase-conjugated secondary antibody at 1:2000 dilution. The membranes were again washed 3 times in wash buffer, after which they were incubated for 2 minutes at room temperature in chemiluminescence reaction detection reagents. The membranes were then exposed to autoradiography film (Hyperfilm), and the relative intensities of the bands were quantified by densitometric analysis (Personal Densitometer SI, Molecular Dynamics). For reprobing for GAPDH, the membranes were stripped at 50°C for 30 minutes in buffer containing 2% SDS, 62.5 mmol/L Tris-HCl (pH 6.8), and 100 mmol/L ␤-mercaptoethanol. The membranes were immunoblotted with GAPDH antibody at 1:5000 dilution.
Cell Culture
Rabbit aortic endothelial cells (RAECs) were isolated from NZW rabbits fed NC. The entire descending thoracic aorta was excised, cleaned, and incubated with 0.08% collagenase at 37°C for 15 minutes. The aorta was rinsed with PBS, and the endothelial cells were flushed out and seeded in plastic plates precoated with 0.1% gelatin and cultured in DMEM-low glucose supplemented with 10% FBS, 12.5 g/mL endothelial cell growth supplement, 25 U/mL heparin, 100 U/mL penicillin, and 100 g/mL streptomycin. Culture plates with 90% confluent endothelial cells were subsequently trypsinized with 0.25% trypsin-EDTA for 5 minutes and reseeded in gelatin-coated (0.1%) plates, and cells from the third passage were used for experiments. Cells were identified as endothelial by their characteristic cobblestone morphology. Before the cells were used, they were incubated with E 2 for 48 hours and tested for the presence of estrogen receptors with RT-PCR as described below. Cells were placed in medium containing phenol red-free DMEM and charcoalextracted FBS. Cells were then treated as described in protocol 4.
Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
RAECs (10 6 cells) were harvested, and total RNA was extracted using Tri-Reagent as described by the Molecular Research Center. Reverse transcription was performed with 3 g of total RNA, 50 units of Moloney murine leukemia reverse transcriptase, and 100 pmol of oligo-dT and running the reaction at 42°C for 20 minutes. The resulting cDNA samples were PCR-amplified using the GeneAmp RNA PCR kit and 100 ng each of estrogen receptor sense and antisense primers in a 100-L reaction mixture. The amplification procedure consisted of initial heat denaturation at 94°C for 5 minutes followed by PCR amplification of estrogen receptor cDNA for 40 cycles each of denaturation at 94°C for 30 seconds, primer annealing at 55°C for 30 seconds, and extension at 72°C for 1 minute. The following set of primers was used for estrogen receptor: sense, 5Ј-AGGAAGAGCTGCCAGGCCT-3Ј, and antisense, 5Ј-CCAGTTGATCATGTGAACCAG-3Ј. 17 The primers were obtained from Custom Primers (Gibco-BRL). The amplified DNA fragment obtained was 381 bp, as expected. The PCR product was cloned into TA vector pCR 2.1, and its identity as estrogen receptor was confirmed by DNA sequencing (data not shown).
Fluorescence-Activated Cell Sorting (FACS)
After various incubations as described in protocol 4, the cells were trypsinized, collected in tubes, and washed 3 times with PBS. Cells (5ϫ10 5 ) were resuspended in 50 L PBS. Rabbit VCAM-1 mouse monoclonal antibody (Rb 1/9; 2 g) was added to each tube, which was kept shaking for 2 hours on ice. The cells were washed with cold PBS 4 times and incubated with FITC-conjugated goat F(abЈ) 2 
Lipid Assays
Plasma total cholesterol, HDL, and LDL were measured in each animal. All samples were analyzed in triplicate using enzymatic colorimetric assays as described previously. 18 -20 The assays were performed in the Molecular Biology Institute Lipid and Lipoprotein Laboratory (University of California, Los Angeles, CA). This laboratory is certified by the Centers for Disease Control and PreventionNational Heart, Lung and Blood Institute Lipid Standardization Program and meets their criteria for precision and accuracy.
Radioimmunoassay for E 2
The plasma concentrations of E 2 were measured by radioimmunoassay as previously described. 21 Briefly, 0.6 to 0.8 mL plasma containing known amounts (Ϸ400 cpm) of [ 3 H]E 2 were extracted with 7 mL fresh dimethyl ether, and the extract was evaporated to dryness. The dried plasma extract was dissolved in isooctane and then applied to a column of infusorial earth (Celite) for chromatographic separation of E 2 , as described by Brenner et al. 22 Steroid fractions collected from the column were dried and reconstituted with assay buffer for radioimmunoassay. The results showed that peaks of radioactive and immunoreactive estrogens coincided in Celite column fractions. 21 
Statistics
Values are expressed as meanϮSEM. Comparisons of means were made by using the Student t test for unpaired values; when more than 2 means were compared, an ANOVA with repeated measurements was used. If a significant F value was found, the Scheffé test for multiple comparisons was used to identify differences among groups. Values were considered significant when PϽ0.05.
Results
Protocol 1: Gender Differences in Monocyte Adhesion in Gonad-Intact Rabbits Fed Normal or Cholesterol-Enriched Chow
The mean cholesterol AUCs for gonad-intact female and male rabbits fed NC for 4 weeks were 482Ϯ131 and 277Ϯ94 mg/dL, respectively, and were not significantly different from one another (PϾ0.5). Mean HDL and LDL AUCs were not different between groups (data not shown). The mean E 2 levels were higher in the female (25Ϯ2 pg/mL) as compared with the male (18Ϯ1 pg/mL) rabbits (PϽ0.05). The mean numbers of adherent monocytes per 13.5 mm 2 in females and males were 0 and 1.4Ϯ1.2 monocytes per 13.5 mm 2 , respectively, and were not significantly different from one another.
The mean cholesterol AUCs for gonad-intact female and male rabbits after 4 weeks of HC were not significantly different from one another throughout the feeding period (PϾ0.05) (Figure 2 ). Mean HDL and LDL AUCs were not different between groups (data not shown). The mean number of monocytes adherent to the endothelial surface and the number that migrated subendothelially were significantly lower in the female as compared with the male animals ( Figure 3) , and the mean E 2 levels were higher in the female as compared with the male animals ( Figure 3) , indicating an inverse relationship between E 2 levels and monocyte adhesion and subendothelial migration in hypercholesterolemic animals.
Protocol 2: Effects of E 2 Supplementation on Monocyte Adhesion in Ovariectomized Animals Fed a Cholesterol-Enriched Diet
The mean cholesterol AUCs throughout the feeding period for animals supplemented with OVX/placebo and OVX/E 2 were not significantly different from one another (PϾ0.05) (Figure 2 ). Mean HDL and LDL AUCs were also not different between groups (data not shown). The mean number of monocytes adherent to the endothelial surface and the number that migrated subendothelially were significantly greater in the placebo-supplemented than in the E 2 -supplemented animals (Figure 4) , and the mean E 2 levels were significantly lower in the placebo-supplemented than in the E 2 -supplemented animals (Figure 4) , again demonstrating an inverse relationship between E 2 levels and monocyte adhesion and subendothelial migration in animals fed a cholesterol-enriched diet. Representative photomicrographs depicting this relationship are shown in Figure 1 .
Protocol 3: Effects of E 2 Supplementation on VCAM-1 Protein Expression in Ovariectomized Animals Fed a Cholesterol-Enriched Diet
OVX/placebo-supplemented animals placed on HC demonstrated an increase in VCAM-1 protein expression as compared with that seen in OVX/placebo-supplemented animals placed on NC. In all animals, this increase was attenuated by supplementation with E 2 . In Figure 5 is shown a Western blot from representative animals in each group, and in Figure 6 is a scatterplot of the arbitrary densitometric units of data from 5 individual animals in the cholesterol-fed groups that received either placebo or E 2 when the Western blot was run on the same gel. In some experiments, we compared the expression of VCAM-1 with GAPDH. We consistently observed a decrease in VCAM-1 expression in E 2 -supplemented animals with no change in GAPDH expression (data not shown).
Protocol 4: Effects of E 2 Supplementation on VCAM-1 Protein Expression in Cultured Endothelial Cells Stimulated With Lyso-PC
Lyso-PC at 100 mol/L increased the cellular content of VCAM-1 protein by 248% as compared with vehicle (data not shown). E 2 inhibited this increase in a concentrationdependent fashion (Figure 7 ). Figure 8 shows the representative traces of FACS analysis from 2 separate experiments. ICI-182780 abolished the effects of E 2 .
Discussion
The mechanisms by which females are protected from the development of atherosclerosis compared with males and the role that estrogen plays in this process are not known. The primary objective of this study was to assess whether there was a gender difference in the adhesion of monocytes to endothelial cells in vivo in animals fed a cholesterol-enriched at the celiac bifurcation in male and female rabbits after 4 weeks of HC). Right, E 2 levels in the same rabbits depicted in the left panel at the end of the 4-week feeding period. Data are expressed as meanϮSEM of 8 animals in each group. *PϽ0.05 denotes significant difference in number of adherent monocytes between male and female animals (left) and in E 2 levels between male and female animals (right). diet and whether this can be explained on the basis of circulating E 2 .
Our studies demonstrate in vivo that adhesion of monocytes to endothelial cells is retarded in females as compared with males. This difference was not mediated by any changes in circulating lipids, as the male and female animals used for the study had comparable lipid levels. Thus, reduced monocyte adhesion in females may be a partial explanation for the gender differences in the extent of atherosclerosis previously reported in this species. 11, 12 To elucidate whether the higher E 2 levels seen in the ovary-intact females accounted for the gender difference in monocyte adhesion in vivo, we studied this phenomenon in ovariectomized rabbits either supplemented with placebo or supplemented with 1.5-mg, 60-day release E 2 pellets. These pellets provide near-physiological concentrations of E 2 , which are concentrations comparable with those seen in ovary-intact rabbits. In ovariectomized rabbits supplemented with E 2 , there were both significantly fewer monocytes adherent to endothelial cells and fewer subendothelial monocytes when compared with ovariectomized animals supplemented with placebo at 4 weeks of hypercholesterolemia. Again, this action of E 2 was not due to any E 2 -induced changes in circulating lipids. It is interesting to note that the number of monocytes adherent to the endothelium in ovariectomized animals supplemented with placebo was significantly higher as compared with gonad-intact males. The role of circulating androgens on monocyte endothelial interactions was not addressed in this study. However, it is possible that androgens such as testosterone are converted into E 2 by the aromatase activity present in endothelial cells. 23 Products of lipid oxidation can activate the endothelium to support a specific increase in the adhesion of monocytes and T lymphocytes, but not polymorphonuclear leukocytes. 13, 24, 25 VCAM-1 is likely to be the adhesion molecule responsible for providing this specificity. 26 -28 VCAM-1 is a member of the IgG superfamily 29 and interacts with its counterreceptor, the very late appearing antigen 4 (VLA-4), a ␤ 1 -integrin expressed on the surface of monocytes and lymphocytes but not on polymorphonuclear leukocytes. 30, 31 In fatty streaks of rabbits with diet-induced or genetically determined hypercholesterolemia, the endothelial cells express VCAM-1 focally. 32 Furthermore, the expression of VCAM-1 occurs in lesionprone areas of the rabbit aorta as early as 1 week after initiation of a hypercholesterolemic diet before intimal macrophages accumulate. 32 Our results demonstrated that E 2 administration at physiological concentrations to ovariectomized rabbits fed a cholesterol-enriched diet markedly decreased VCAM-1 expression when compared with ovariectomized rabbits implanted with a placebo pellet. We did not specifically evaluate whether the VCAM-1 was expressed predominantly in the endothelial cells or vascular smooth muscles. However, other investigators 33 have reported that in Figure 5 . Western blot analysis of VCAM-1 protein in aorta of female rabbits that were ovary-intact and fed NC (lane 1); ovariectomized, supplemented with placebo, and fed high-cholesterol diet (lanes 2 and 3) ; or ovariectomized, supplemented with E 2 , and fed high-cholesterol diet (lanes 4 and 5). Each lane represents 1 animal, which was representative of its respective group (nϭ5). at the celiac bifurcation in OVX/placebo (P)-and OVX/E 2 -supplemented rabbits after 4 weeks of HC. Right, E 2 levels in the same rabbits depicted in the left panel at the end of the 4-week feeding period. Data are expressed as meanϮSEM of 6 or 7 animals in each group. *PϽ0.05 denotes significant difference in number of adherent monocytes between OVX/placebo and OVX/E 2 animals (left) and in E 2 levels between OVX/placebo and OVX/E 2 animals (right). rabbits fed a cholesterol-enriched diet for 6 weeks or less, VCAM-1 was expressed predominantly in endothelial cells. It is therefore likely that the differences in VCAM-1 expression observed in our studies were due to differences in endothelial cell VCAM-1 expression. Results from our studies do not indicate whether the effects of E 2 in decreasing VCAM-1 expression in vivo are a result of its antioxidant properties 34, 35 or whether this action is mediated by the binding of E 2 to its receptor in endothelial cells.
To corroborate our in vivo data and to try and determine the mechanism by which E 2 regulates VCAM-1 expression, we also investigated whether there was a corresponding effect of E 2 in the presence of an estrogen receptor antagonist on VCAM-1 protein expression by RAECs in vitro. We used lyso-PC to activate our endothelial cells, as lyso-PC is a major chemotactic lipid component of both oxidized LDL and ␤-VLDL. 36, 37 In addition, the concentration of lyso-PC is increased in atherosclerotic arterial lesions in animals fed an atherogenic diet 38 and has been demonstrated to be a selective chemoattractant for mononuclear leukocytes. 36 Lyso-PC has also been shown to selectively induce both VCAM-1 and intracellular adhesion molecule-1 in RAECs. 39 In keeping with previous studies, 39 we also observed that lyso-PC (100 mol/L) induced the expression of VCAM-1 on endothelial cells. Our results further indicated that E 2 at concentrations of 1000 and 3000 pg/mL reduced the surface expression of VCAM-1 on endothelial cells in culture in the presence of lyso-PC. This action of E 2 in attenuating VCAM-1 expression in vitro was abolished in the presence of the E 2 antagonist, ICI-182780, which blocks the interaction of E 2 with the estrogen receptor. 16 This suggests that the action of E 2 in regulating VCAM-1 expression was at least in part due to the interaction of E 2 with its receptor and not via an indirect antioxidant effect of E 2 .
The action of E 2 in modulating VCAM-1 expression in endothelial cells has also been studied by other investigators, but only in vitro, and the results are controversial. In studies of human umbilical vein endothelial cells (HUVECs), E 2 suppressed the induction of VCAM-1, E-selectin, and intracellular adhesion molecule-1 mRNA expression by interleukin-1␤. 40, 41 In contrast, Cid et al 42 observed that E 2 did not affect basal VCAM-1 expression but caused a 30% to 50% increase in the presence of tumor necrosis factor (TNF) and had no effect when the HUVECs were stimulated with IL-1. It has also been reported that E 2 increased the TNF-␣-induced expression of E-selectin in endothelial cells in culture but had no effect on the expression of VCAM-1. 43 These contrasting observations may in part be due to differences in the cell types used (HUVECs versus RAECs) and the degree to which they express estrogen receptors, differences in the concentrations of E 2 administered (ranging from 50 to 5000 pg/mL), and differences in the agents used to induce VCAM-1 expression (lyso-PC, IL-1␤, and TNF-␣).
In this regard, in both the present study and in those previously reported, the concentrations of E 2 required for inhibition of VCAM-1 expression in vitro were in the supraphysiological range. This is in sharp contrast to the E 2 -mediated inhibition of VCAM-1 expression in vivo that Figure 7 . Flow cytometric analysis of the inhibitory effects of E 2 on Lyso-PC-mediated VCAM-1 induction. f, Cells were treated with Lyso-PC (100 mol/L) for 15 hours; o, single dose E 2 1000 pg/mL for 48 hours followed by stimulation with Lyso-PC (100 mol/L) for 15 hours; Ⅺ, single dose E 2 3000 pg/mL for 48 hours followed by stimulation with Lyso-PC (100 mol/L) for 15 hours; 1, ICI-182780 and then E 2 3000 pg/mL for 48 hours followed by stimulation with Lyso-PC (100 mol/L) for 15 hours. Data depict VCAM-1 induction in the presence of E 2 alone or in combination with the estrogen receptor antagonist ICI-182780 and are expressed as a percentage of the induction achieved with Lyso-PC alone. Data are expressed as meanϮSEM of 5 separate experiments. occurred at physiological E 2 concentrations. At present, it is unclear why there is this discrepancy between the concentration of E 2 required for the suppression of VCAM-1 expression in vivo versus in vitro. It is possible that in vivo, E 2 acts by the following 2 mechanisms: inhibition of LDL oxidation with a concomitant decrease in the amount of lyso-PC formed, and a direct estrogen receptor-mediated action on the endothelial cells. Estrogen receptors are present in both endothelial cells and vascular smooth muscles in vivo. 44 -47 However, the relative degree to which estrogen receptors are expressed by these cells under in vitro conditions has not yet been reported. A higher expression of estrogen receptors in vivo could partly explain why lower concentrations of circulating E 2 inhibit VCAM-1 expression in vivo relative to the much higher concentrations of E 2 required in vitro. It is also possible that E 2 may be converted into a more active metabolite in vivo, which may also partially account for the higher concentrations of E 2 required to suppress VCAM-1 expression in vitro. Further work is in progress to assess this aspect.
Finally, our data also demonstrated that E 2 administration reduced the number of monocytes that migrated into the subendothelial space. This could simply be a result of the reduction in the number of adhesion sites. However, this may also be due to an E 2 -mediated inhibition of expression of monocyte-specific chemokines. For example, in preliminary studies of a similar group of hypercholesterolemic rabbits, we observed that E 2 inhibits expression of the monocyte chemotactic protein-1 (MCP-1). 48 Thus, estrogen appears to have the combined property of inhibiting both monocyte adhesion and the subsequent recruitment of monocytes into the arterial intima.
Monocyte adhesion and subendothelial migration are key cellular events generally associated with the initiation of the atherogenic process. In this regard, an estrogen-mediated inhibition of these processes could not account for the fact that the protection against CVD seen in women does not manifest itself until middle age, when inflammatory cell-rich fatty streaks have generally progressed to more advanced atherosclerotic lesions. However, monocyte recruitment is part of a fibroproliferative inflammatory response that is continuous throughout the entire atherogenic process. For example, VCAM-1 expression with an associated leukocyte infiltration has been demonstrated in microvessels within advanced human plaques. 49 Furthermore, there is now ample evidence that advanced plaques most frequently rupture at sites enriched with inflammatory cells and lipid. 50, 51 Plaque rupture in turn leads to the formation of occlusive thrombosis and the clinical sequelae of CVD. Thus, the effect of estrogen in inhibiting VCAM-1 and MCP-1 expression and monocyte adhesion and subendothelial migration is likely to have a profound impact on all stages in the atherogenic process and may also account for the protective effects in women before menopause.
In conclusion, our results suggest that reduced inflammatory cell infiltration into the artery wall due to an estrogenmediated inhibition of the expression of VCAM-1 and/or MCP-1 48 is in part responsible for the protection from atherosclerosis that is seen in women.
